Thank you for joining us here. Beautiful view in the background. Happy to be here.We have seen the NFL and the NBA do major media rights deals, getting significant increases in dollars for their teams and owners over the past few years. You guys are up in 2028 but the most recent data point we have for you is ESPN opting out of their Sunday package, saying we're paying too much for this package. So my question for you to start is, are you confident that you can deliver another significant rights fee increas ...

These are the most impactful pioneers ensuring and expanding the civil rights of people with disabilities all across the globe: https://t.co/GMZ1ATtm0Y https://t.co/3E8V2npTIK ...

Legal & Political Landscape - The European Court of Human Rights faces potential challenges if it doesn't adapt [1] - Right-wing ideologies pose a threat to the European Court of Human Rights [1]

The federal government is now requesting states to hand over their federal roles. There's a reason why they want access to look at your voting machines. Folks, this is outside the purview of the federal government.They have no business looking at voting machines. That's a state responsibility. They can ask questions to make sure that there's safeguards in place.Sure. But at the end of the day, it is the state that is the is the responsible party here. The second part of this, and I'd like to get your commen ...

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Krispy Kreme, Inc. due to a class action lawsuit alleging breaches of fiduciary duties by the board of directors during a specified class period [1][2]. Group 1: Class Action Lawsuit Details - The class action lawsuit claims that Krispy Kreme made false or misleading statements regarding the demand for its products at McDonald's locations, which significantly declined after the initial marketing launch [2]. - It is alleged that the declining demand at McDonald's contributed to a decrease in average sales per door per week and that the partnership with McDonald's was not profitable, posing risks to the continuation of this partnership [2]. - The lawsuit also states that Krispy Kreme would pause its expansion into new McDonald's locations due to these issues [2]. Group 2: Financial Performance - On May 8, 2025, Krispy Kreme reported its first quarter 2025 financial results, revealing net revenue of $375.2 million, a decline of 15.3% compared to the previous year [3]. - The company also reported a net loss of $33.4 million, a significant increase from the prior year's net loss of $6.7 million [3]. - Following the release of these financial results, Krispy Kreme announced it would reassess its deployment schedule with McDonald's and withdrew its prior full-year outlook, citing uncertainty around the McDonald's deployment schedule [3]. - The announcement led to a nearly 25% drop in Krispy Kreme's share price [3].

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against National Grid plc for possible violations of federal securities laws and unlawful business practices following a fire incident at Heathrow Airport linked to the company [2][3]. Group 1: Incident Overview - On July 1, 2025, the National Energy System Operator published a report indicating that a fire at Heathrow Airport on March 20, 2025, was caused by a known fault at an electrical substation owned by National Grid, which had been aware of the issue since 2018 but did not address it [3]. - Following the report, Heathrow Airport is reportedly considering legal action against National Grid [3]. Group 2: Market Reaction - The news of the incident and subsequent investigation led to a decline in National Grid's American Depositary Receipt (ADR) price, which fell by $3.77, or 5.07%, closing at $70.61 per ADR on July 2, 2025 [4]. Group 3: Legal Representation - Bragar Eagel & Squire, P.C. is reaching out to National Grid stockholders who may have suffered losses and encourages them to discuss their legal rights [1][5].

For reference on said meetinghttps://t.co/T4FhgWzVwAmakesy 🟢 (@0xMakesy):Just checked out the YHC bylaws- per a November 2024 amendment, special meetings can be called by owners of 33 1/3% of voting shares (less than usual 50% threshold)- directors can be removed with a 2/3 vote of shareholdersCall the meeting with haste @rleshner @matt_levine https://t.co/NnB9OUMsKA ...

Core Viewpoint - A class action lawsuit has been filed against Biohaven Ltd. for allegedly misleading investors regarding the viability of its drug candidates, particularly troriluzole and BHV-7000 [1][2]. Group 1: Company Overview - Biohaven Ltd. is a biopharmaceutical company focused on developing therapies in immunology, neuroscience, and oncology [1]. - The company is working on several product candidates, including troriluzole for spinocerebellar ataxia (SCA) and BHV-7000 for bipolar disorder [1]. Group 2: Allegations - The lawsuit claims that Biohaven overstated the regulatory prospects and data sufficiency for troriluzole as a treatment for SCA [2]. - It is also alleged that the efficacy and clinical prospects of BHV-7000 for bipolar disorder were similarly overstated [2]. - The revelations from the lawsuit are expected to have a significant negative impact on Biohaven's business and financial condition [2]. Group 3: Legal Proceedings - Shareholders interested in serving as lead plaintiffs must file their papers by September 12, 2025 [3]. - Participation in the case is not required to be eligible for recovery, allowing shareholders to remain absent class members if they choose [3].

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Laser Photonics Corporation for possible violations of federal securities laws and unlawful business practices [1][3]. Financial Disclosure Issues - On September 23, 2024, Laser Photonics announced that its previously issued financial statements for the year ended December 31, 2023, and the quarter ended June 30, 2024, should no longer be relied upon due to an overstatement of deferred revenue identified by its predecessor auditor, Fruci & Associates II, PLLC [3]. - Following this announcement, Laser Photonics' stock price dropped by $6.90 per share, or 36.7%, closing at $11.90 per share on September 25, 2024 [3]. Legal Rights and Investor Support - Investors who purchased or acquired Laser Photonics shares and suffered losses are encouraged to contact Bragar Eagel & Squire for information regarding their legal rights and potential claims [1][4].

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Elevance Health, Inc. due to a class action lawsuit alleging that the company misled investors regarding the impact of Medicaid redetermination on its financial guidance and cost trends [1][2]. Group 1: Legal Investigation - The law firm is representing long-term stockholders of Elevance who held shares between April 18, 2024, and October 16, 2024, following a class action complaint filed on May 12, 2025 [1]. - The investigation focuses on whether Elevance's board of directors breached their fiduciary duties to the company [1]. Group 2: Allegations in the Lawsuit - The lawsuit claims that Elevance made false or misleading statements about its monitoring of cost trends related to the Medicaid redetermination process [2]. - It is alleged that while Elevance acknowledged rising Medicaid expenses, it misrepresented that these were adequately reflected in its financial guidance for 2024 [2]. - The lawsuit highlights that the redetermination process led to a significant increase in the acuity and utilization of Medicaid members, contrary to the company's assurances [2]. Group 3: Contact Information - Investors seeking more information or wishing to discuss their rights can contact Brandon Walker or Marion Passmore at Bragar Eagel & Squire, P.C. via phone or email [3][6].